Recap: Pacific Biosciences Q4 Earnings - Pacific Biosciences (NASDAQ:PACB)

Pacific Biosciences PACB reported its Q4 earnings results on Tuesday, February 15, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Pacific Biosciences missed estimated earnings by 7.14%, reporting an EPS of $-0.3 versus an estimate of $-0.28.

Revenue was up $8.88 million from the same period last year.

Last quarter the company missed on EPS by $0.01, which was followed by a 5.55% increase in the share price the next day.

Here's a look at Pacific Biosciences's past performance:

Quarter	Q3 2021	Q2 2021	Q1 2021	Q4 2020
EPS Estimate	-0.22	-0.20	-0.45	0.32
EPS Actual	-0.23	-0.21	-0.45	0.37
Revenue Estimate	33.23M	29.89M	25.67M	25.41M
Revenue Actual	34.89M	30.61M	29.00M	27.14M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.